[
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These models display some of the histopathological features of human GBM, including infiltration of tumor cells throughout the surrounding brain parenchyma (Fig. 1), areas of necrosis, micro-vascular hyperplasia, hemorrhages, presence of palisades; they are technically relatively easy to develop and highly reproducible [10, 12, 16-19], constituting a good model to test therapeutic efficacy in vivo.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The highest circulating levels of HMGB1 were reached when tumor-bearing animals are treated with a cytotoxic-immunotherapeutic gene therapy approach that led to tumor regression and long term survival [15, 20, 21], as described below (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The released tumor antigens are then taken up by the infiltrating dendritic cells, transported to the draining lymph nodes, where T cells are primed to induce a cytotoxic T cell response which is able to induce brain tumor regression and immunological memory (Fig. 2) [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Since these agents exert their cytotoxic effect only in proliferating cells, their pro-apoptotic effects are very specific to GBM cells when delivered within the brain (Fig. 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Importantly, efficacy of Ad-TK+GCV treatment was tested in several rat and mouse brain tumor models (Fig. 4) [15, 21].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  }
]